David Nicholson - Gilde Healthcare

team
Venture&Growth

All team members
David Nicholson
Operational Partner
United States of America

David Nicholson

Operational Partner

David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a division at Bayer; Vice President of Licensing and Knowledge Management at Merck; and Senior Vice President, responsible for Global Project Management and Drug Safety at Schering-Plough. From 1988 to 2007, Dr. Nicholson held various leadership positions at Organon, where he most recently served as Executive Vice President, Research & Development and was a member of the company’s Executive Management Committee. He received a B.Sc. from the University of Manchester and his Ph.D. from the University of Wales.

Arthur Franken

General Partner Healthtech/Therapeutics
Venture&Growth
Arthur Franken joined Gilde in 2001 and was part of the founding team of Gilde Healthcare. He is focusing on venture and growth capital investments in the biopharm, medtech, diagnostics and digital health sectors. He...

Edward Hanlon

Associate Healthtech
Venture&Growth
Edward Hanlon joined Gilde Healthcare in 2020 in the Cambridge office and focuses on Healthtech. Prior to joining Gilde, Edward worked in advisory for Health Advances, a consulting firm operating across healthcare sectors in medical...

Sanne de Jongh

Investment Manager Therapeutics
Venture&Growth
Sanne de Jongh joined Gilde Healthcare in 2017 and focuses on the biopharmaceutical sector. She is involved in deal sourcing, assessment of investment cases and portfolio management. She represents Gilde on the board of Calypso...